CEO Secrets Unpopular Choices for Success Deniz Kent, co-founder and CEO of Prolific Machines, discusses his journey from academia to entrepreneurship, emphasizing the resilience instilled by his immigrant background and his strategy of raising capital proactively to gain leverage. What this video coversIn the world of biotech, where cutting-edge research often remains locked within academic institutions, Deniz Kent, Ph.D., is defying convention. He is the co-founder and CEO of Prolific Machines, a company he created on the radical idea of controlling biology with light.Prolific Machines has secured capital from top-tier investors like Pledge Ventures, IndieBio, Ki Tua Fund, and Breakthrough Energy Ventures.Deniz Kent transitioned from academic research to entrepreneurship by founding Prolific Machines, driven by a desire to solve limitations in biological control tools.Prolific Machines uses optogenetics—controlling cells with light—to revolutionize biomanufacturing with higher precision and lower costs.Due to stronger economics and market demand, the company pivoted from growing cultured meat to manufacturing therapeutic proteins.Deniz has raised over $90M from top investors, including IndieBio, Mayfield, Breakthrough Energy Ventures, and Fonterra.He emphasizes raising capital when you don’t need it, to maximize leverage and terms.His immigrant background instilled resilience and a strong work ethic that shaped his entrepreneurial mindset.Deniz believes all biomanufacturing will become optogenetic due to light’s unmatched control and cost efficiency. More from the libraryRevolutionary Idea Ahead of Its Time & Lasting ImpactStartup Life vs Big Tech Why I Chose the EdgeKnow What You Don'tUnexpected Acquisition DealHow To Hire The Best EmployeesNot Everyone Deserves You Watch on Startup Fundraising · Open on YouTube · More shorts
